Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Atara Biotherapeutics Inc (NASDAQ: ATRA) was $8.59 for the day, down -1.49% from the previous closing price of $8.72. In other words, the price has decreased by -$1.49 from its previous closing price. On the day, 57558.0 shares were traded. ATRA stock price reached its highest trading level at $8.98 during the session, while it also had its lowest trading level at $8.29.
Ratios:
Our analysis of ATRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on November 09, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $31 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 18 ’24 when Henrich Jill sold 1,000 shares for $11.20 per share. The transaction valued at 11,198 led to the insider holds 19,378 shares of the business.
Hyllengren Eric J sold 1,364 shares of ATRA for $15,274 on Nov 18 ’24. The EVP, CFO and COO now owns 23,392 shares after completing the transaction at $11.20 per share. On Nov 18 ’24, another insider, Nguyen AnhCo, who serves as the President and CEO of the company, sold 1,664 shares for $11.20 each. As a result, the insider received 18,633 and left with 77,454 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATRA now has a Market Capitalization of 49476252 and an Enterprise Value of 32188252. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49. Its current Enterprise Value per Revenue stands at 0.32 whereas that against EBITDA is -0.282.
Stock Price History:
The Beta on a monthly basis for ATRA is 0.45, which has changed by -0.5909524 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, ATRA has reached a high of $23.44, while it has fallen to a 52-week low of $5.40. The 50-Day Moving Average of the stock is -22.20%, while the 200-Day Moving Average is calculated to be -18.50%.
Shares Statistics:
ATRA traded an average of 214.48K shares per day over the past three months and 124270 shares per day over the past ten days. A total of 5.74M shares are outstanding, with a floating share count of 3.73M. Insiders hold about 35.26% of the company’s shares, while institutions hold 41.38% stake in the company. Shares short for ATRA as of 1738281600 were 706465 with a Short Ratio of 3.29, compared to 1735603200 on 533616. Therefore, it implies a Short% of Shares Outstanding of 706465 and a Short% of Float of 12.42.
